Pharmacological management of the psychiatric aspects of traumatic brain injury

Research output: Contribution to journalReview articlepeer-review

Abstract

Traumatic brain injury (TBI) is a significant public health problem that affects millions of people annually in the USA. Neuropsychiatric symptoms such as cognitive deficits, depression, mania, anxiety, psychosis, apathy, and sleep disturbance are common after TBI. An extensive array of pharmacological options are available to treat a wide range of neuropsychiatric sequelae of TBI, yet there have been few controlled clinical trials to assess the effects of pharmacotherapy in TBI patients. Treatment of the neuropsychiatric disturbances associated with TBI should result in decreased handicap, improved quality of life, and decreased societal impact. There is a dire need for large, randomized, double blind, placebo-controlled trials that include a broad range of cognitive and behavioral outcome measures.

Original languageEnglish (US)
Pages (from-to)359-370
Number of pages12
JournalInternational Review of Psychiatry
Volume15
Issue number4
DOIs
StatePublished - Nov 2003

ASJC Scopus subject areas

  • Psychiatry and Mental health

Fingerprint

Dive into the research topics of 'Pharmacological management of the psychiatric aspects of traumatic brain injury'. Together they form a unique fingerprint.

Cite this